VACCINATION UPTAKE IN A COHORT OF PATIENTS ON BIOLOGIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS (BDMARDS) AT A MELBOURNE PUBLIC HOSPITAL

被引：0
|
作者：
Pourhadi, Hedayat [1 ]
Johnson, Amy [1 ]
Foote, Andrew [1 ]
机构：
[1] Northern Hlth, Epping, NSW, Australia
来源：
INTERNAL MEDICINE JOURNAL | 2023年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
ARA-P113
引用
收藏
页码：51 / 52
页数：2
相关论文
共 50 条
  • [21] SERUM TROUGH LEVELS OF BIOLOGIC DISEASE MODIFYING ANTI-RHEUMATIC DRUGS (BDMARDS) INVERSELY CORRELATE WITH DISEASE ACTIVITY IN PATIENTS WITH INFLAMMATORY ARTHRITIS
    Wong, Peter
    Bowling, Alison
    Bagga, Hanish
    Giammichele, Ms Demi Rose
    Hobson, Peter
    Langguth, Daman
    INTERNAL MEDICINE JOURNAL, 2020, 50 : 25 - 25
  • [22] Cardiovascular Risk of Synthetic, Non-Biologic Disease-Modifying Anti-Rheumatic Drugs (DMARDs)
    Mourouzis, Iordanis S.
    Manolis, Antonis S.
    Pantos, Constantinos
    CURRENT VASCULAR PHARMACOLOGY, 2020, 18 (05) : 455 - 462
  • [23] Therapeutic Utility and Adverse Effects of Biologic Disease-Modifying Anti-Rheumatic Drugs in Inflammatory Arthritis
    Min, Hong Ki
    Kim, Se Hee
    Kim, Hae-Rim
    Lee, Sang-Heon
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (22)
  • [24] RHEUMATOID-ARTHRITIS - DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS
    KIRWAN, JR
    CURREY, HLF
    CLINICS IN RHEUMATIC DISEASES, 1983, 9 (03): : 581 - 599
  • [25] COVID-19 and Disease-Modifying Anti-rheumatic Drugs
    Kristin M. D’Silva
    Zachary S. Wallace
    Current Rheumatology Reports, 2021, 23
  • [26] Biologic and targeted synthetic disease-modifying anti-rheumatic drugs improve body composition in rheumatoid arthritis patients more than conventional synthetic disease-modifying anti-rheumatic drugs: Results from the PRESENT study
    Tada, Masahiro
    Matsumoto, Yoshinari
    Koike, Tatsuya
    Mamoto, Kenji
    Nakamura, Tomoyuki
    Anno, Shohei
    Iida, Takahiro
    Goto, Hitoshi
    Hidaka, Noriaki
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2024, 27 (10)
  • [27] COVID-19 and Disease-Modifying Anti-rheumatic Drugs
    D'Silva, Kristin M.
    Wallace, Zachary S.
    CURRENT RHEUMATOLOGY REPORTS, 2021, 23 (05)
  • [28] Decreased chronic kidney disease in rheumatoid arthritis in the era of biologic disease-modifying anti-rheumatic drugs
    Hanaoka, Hironari
    Kikuchi, Jun
    Hiramoto, Kazuoto
    Saito, Shuntaro
    Kondo, Yasushi
    Kaneko, Yuko
    CLINICAL KIDNEY JOURNAL, 2022, 15 (07) : 1373 - 1378
  • [29] REAL-WORLD USAGE OF BIOLOGIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS IN PATIENTS WITH PSORIATIC ARTHRITIS IN GERMANY
    Song, J.
    Anjohrin, S.
    Abe, C.
    Banefelt, J.
    Rieem, Dun A.
    Picker, N.
    Kromer, D.
    Fuchs, A.
    Hahn, P.
    Welby, S.
    VALUE IN HEALTH, 2023, 26 (12) : S305 - S305
  • [30] Risk factors for bone loss in patients with rheumatoid arthritis treated with biologic disease-modifying anti-rheumatic drugs
    Tawaratsumida H.
    Setoguchi T.
    Arishima Y.
    Ohtsubo H.
    Akimoto M.
    Ishidou Y.
    Nagano S.
    Taketomi E.
    Sunahara N.
    Komiya S.
    BMC Research Notes, 10 (1)
12345